Variable | crOR (CI) | P value | aOR (CI) | P value | ||
---|---|---|---|---|---|---|
Clinical malariab | ||||||
Yes | 3.78 | (2.55–5.59) | < 0.0001 | 4.63 | (2.90–7.40) | < 0.0001 |
No | 1.00 | 1.00 | ||||
Age (months) | ||||||
6–11 | 4.87 | (2.39–9.93) | < 0.0001 | 4.40 | (1.82–10.61) | 0.0003 |
12–23 | 2.66 | (1.46–4.86) | 0.0399 | 2.18 | (1.05–4.56) | 0.1179 |
24–35 | 1.29 | (0.73–2.30) | 0.0450 | 0.90 | (0.44–1.88) | 0.0071 |
36–47 | 1.20 | (0.67–2.16) | 0.0186 | 1.11 | (0.56–2.21) | 0.0733 |
48–59 | 1.00 | 1.00 | ||||
Fever in last 2 weeks | ||||||
Yes | 1.75 | (1.21–2.53) | 0.0029 | 1.58 | (1.04–2.39) | 0.0324 |
No | 1.00 | 1.00 | ||||
Alpha1-Acid Glycoprotein | ||||||
Abnormal | 2.50 | (1.64–3.81) | < 0.0001 | 2.13 | (1.36–3.34) | 0.0010 |
Normal | 1.00 | 1.00 | ||||
Serum ferritinc | ||||||
Abnormal | 1.97 | (1.26–3.09) | 0.0031 | 2.37 | (1.40–4.02) | 0.0014 |
Normal | 1.00 | 1.00 | ||||
Alpha-thalassemia | ||||||
Unaffected | 1.01 | (0.66–1.53) | 0.0030 | 0.90 | (0.57–1.42) | 0.0018 |
Affected | 3.62 | (1.84–7.10) | < 0.0001 | 4.08 | (1.74–9.59) | 0.0004 |
Carrier | 1.00 | 1.00 | ||||
Type of place of residence | ||||||
Urban | 1.27 | (0.53–3.01) | 0.5981 | 2.17 | (0.97–4.89) | 0.0601 |
Rural | 1.00 | 1.00 |